Critical issues in nephrology.
Renal and electrolyte problems are common in patients in the ICU. Several advances that occurred in the recent past have been incorporated in the diagnosis and management of these disorders and were reviewed in this article. Unfortunately, many important questions remain unanswered, especially in the area of ARF, where new therapies are anxiously awaited to make the transition from bench to bedside. Better studies are sorely needed to define the best approach to dialysis in patients who have ARF.
Peixoto
Aldo J
AJ
Department of Medicine, Section of Nephrology, Yale University School of Medicine, 333 Cedar Street, 2073 LMP, New Haven, CT 06520, USA. aldo.peixoto@yale.edu
D000137:Acid-Base Imbalance / Q000188:drug therapy; D058186:Acute Kidney Injury / Q000188:drug therapy; D000471:Alkalosis / Q000188:drug therapy; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003422:Critical Care; D016638:Critical Illness; D004298:Dopamine / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D006435:Renal Dialysis / Q000379:methods; D017693:Sodium Bicarbonate / Q000627:therapeutic use
D000935:Antifungal Agents; D002316:Cardiotonic Agents; D000666:Amphotericin B; D017693:Sodium Bicarbonate; D004298:Dopamine